Siemens Healthineers’ RAPIDPoint 500e Blood Gas Analyzer US FDA Clearance to Aid COVID-19 Efforts
Siemens Healthineers’ (Erlangen, Germany) latest critical care testing solution, the RAPIDPoint 500e Blood Gas Analyzer, has received clearance from the US Food and Drug Administration, and is now available in the US, Europe and countries requiring the CE mark. More...01 Apr 2020
Quidel’s Lyra SARS-CoV-2 Secures Expanded Use Authorization from US FDA
Quidel Corporation (San Diego, CA, USA) has received expanded Emergency Use Authorization (EUA) claims from the Food and Drug Administration (FDA) to allow testing for its Lyra SARS-CoV-2 Assay on three additional thermocyclers, namely Applied Biosystems 7500 Standard, Roche LightCycler 480, and Qiagen Rotor-Gene Q.1 More...01 Apr 2020
AI Tool Predicts Which COVID-19 Patients Can Develop Severe Respiratory Disease
A new study has found that an artificial intelligence (AI) tool can accurately predict which patients who have been newly infected with the 2019 coronavirus disease (COVID-19) can go on to develop severe respiratory disease. More...01 Apr 2020
Philips’ Telehealth Solution Allows Remote Screening and Monitoring of COVID-19 Patients
Royal Philips (Amsterdam, the Netherlands) is providing a dedicated and scalable telehealth solution that can help general practitioners (GPs) and healthcare institutions manage the increased patient flows resulting from the COVID-19 outbreak. More...01 Apr 2020
Hardy Diagnostics Releases Autobio’s One-Step Test for COVID-19
Hardy Diagnostics (Santa Maria, CA, USA), an FDA-licensed manufacturer of medical devices for microbiological testing, has begun accepting orders for a new rapid, one-step lateral flowassay that detects both IgG and IgM antibodies to the SARS-CoV-2 virus. More...31 Mar 2020
Sanofi and Regeneron Roll Kevzara into COVID-19 Trials
A phase 2/3, randomized, double-blind, placebo-controlled trial has been initiated to evaluate the safety and efficacy of Kevzara, jointly developed by Sanofi S.A. (Paris, France) and Regeneron Pharmaceuticals, Inc. (Tarrytown, NY, USA), in adults hospitalized with serious complications from COVID-19. More...31 Mar 2020
Novartis Collaborates with Life Sciences Companies for Development of COVID-19 Vaccines and Diagnostics
Novartis AG (Basel, Switzerland) and a consortium of life sciences companies have entered into a collaboration to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19 in response to the pandemic. More...31 Mar 2020
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
New
Blanket Warming Cabinet
EC250
New
In-Bed Scale
IBFL500
In Other News
University of Oxford Develops Rapid Testing Technology for Coronavirus; Starts Clinical Trial of Potential Drug Treatments
Altimmune Partners with University of Alabama to Develop Intranasal Coronavirus Vaccine
Johnson & Johnson Announces Lead Vaccine Candidate for COVID-19
AI Chest CT Analysis Distinguishes COVID-19 from Pneumonia
New Paper-Based Rapid Test for COVID-19 Awaiting FDA EUA Approva
Chembio and LumiraDx Enter into COVID-19 Strategic Partnership
PerkinElmer’s New Nucleic Acid Detection Kit for SARS-CoV-2 Secures FDA EUA Approval
Luminex Receives US FDA Emergency Use Authorization for COVID-19 Virus Detection Test
SARS-Cov-2 Specific Antibody Responses in COVID-19 Patients
Factors Associated with ARDS in COVID-19 Identified
The COVID-19 Coronavirus Remains Viable for Hours or Days on Solid Surfaces
Abbott Launches New Test that Detects Coronavirus in Just Five Minutes
Rapid POC Screening Technology Uses Artificial Glycan Receptor to Detect Coronavirus in 20 Minutes
New Rapid Coronavirus Test Gives Results in Just 15 Minutes
UC San Diego Partners with Diagnostics Manufacturers for COVID-19 Testing; Begins Trial to Assess Antiviral Drug
Randox and Bosch to Launch Game-Changing POC Coronavirus Test
Fulgent Partners with MedScan to Launch Next Generation Sequencing-Based Test for Coronavirus
Abbott Launches Molecular Test for Novel Coronavirus (COVID-19)
GenMark Receives FDA Emergency Use Authorization for ePlex SARS-CoV-2 Test
Diazyme Announces Availability of COVID-19 Antibody Tests
BD, BioGX Submit EUA Request to FDA for New COVID-19 Diagnostics
DiaSorin Receives BARDA Funding to Develop Rapid COVID-19 Test
Mesa Receives FDA EUA for 30 Minute POC Molecular COVID-19 Test
